Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 700,600 $ 946,987
Accounts receivable, net 259,289 326,272
Inventories 145,948 148,717
Prepaid expenses and other assets 538,833 450,893
Total current assets 1,644,670 1,872,869
Property and equipment, net 14,508,426 14,516,366
Goodwill 98,134 98,134
Trade names 500,525 500,525
Other long-term assets 1,598,936 1,569,800
Total assets 18,350,691 18,557,694
Current liabilities:    
Current portion of long-term debt 1,210,248 991,128
Accounts payable 203,233 228,742
Accrued expenses and other liabilities 1,109,029 1,318,460
Advance ticket sales 3,177,026 2,516,521
Total current liabilities 5,699,536 5,054,851
Long-term debt 11,920,504 12,630,402
Other long-term liabilities 830,199 803,850
Total liabilities 18,450,239 18,489,103
Commitments and contingencies (Note 9)
Shareholders' equity:    
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; and 424,158,982 shares issued and outstanding at March 31, 2023 and 421,413,565 shares issued and outstanding at December 31, 2022 424 421
Additional paid-in capital 7,631,028 7,611,564
Accumulated other comprehensive income (loss) (505,364) (477,079)
Accumulated deficit (7,225,636) (7,066,315)
Total shareholders' equity (deficit) (99,548) 68,591
Total liabilities and shareholders' equity $ 18,350,691 $ 18,557,694